RS49710B - Postupak sinteze hloropurinskih intermedijara - Google Patents

Postupak sinteze hloropurinskih intermedijara

Info

Publication number
RS49710B
RS49710B YUP-202/00A YU20200A RS49710B RS 49710 B RS49710 B RS 49710B YU 20200 A YU20200 A YU 20200A RS 49710 B RS49710 B RS 49710B
Authority
RS
Serbia
Prior art keywords
formula
compound
synthesis
situ
salt
Prior art date
Application number
YUP-202/00A
Other languages
English (en)
Inventor
Martin Jones
Christopher John Wallis
Original Assignee
Glaxo Group Limited,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited, filed Critical Glaxo Group Limited,
Publication of YU20200A publication Critical patent/YU20200A/sh
Publication of RS49710B publication Critical patent/RS49710B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Postupak dobijanja jedinjenja formule (I), opciono u obliku njegove soli ili kompleksa, naznačen time, što se sastoji od hidrolize jedinjenja formule (IV), gde je P zaštitna grupa, u prisustvu kiseline, kondenzovanja proizvoda formule (V) stvorenog in situ u polarnom rastvaraču, u prisustvu baze, sa jedinjenjemformule (VI) u kome R predstavlja CHO ili H, i nakon toga in situ zatvaranjem u prsten nastalog intermedijara formule (VII) gde R predstavlja CHO ili H, uz stvaranje jedinjenja formule (I), koje zatim opciono može da reaguje sa kiselinom ili sredstvom za kompleksiranje dajući njegovu so ili kompleks.- Prijava sadrži još 12 patentnih zahteva.
YUP-202/00A 1997-10-14 1998-10-14 Postupak sinteze hloropurinskih intermedijara RS49710B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721780.6A GB9721780D0 (en) 1997-10-14 1997-10-14 Process for the synthesis of chloropurine intermediates

Publications (2)

Publication Number Publication Date
YU20200A YU20200A (sh) 2003-02-28
RS49710B true RS49710B (sr) 2007-12-31

Family

ID=10820547

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-202/00A RS49710B (sr) 1997-10-14 1998-10-14 Postupak sinteze hloropurinskih intermedijara

Country Status (44)

Country Link
US (1) US6646125B1 (sr)
EP (1) EP1023292B1 (sr)
JP (1) JP4531250B2 (sr)
KR (1) KR100543845B1 (sr)
CN (1) CN1160354C (sr)
AP (1) AP1182A (sr)
AR (1) AR014921A1 (sr)
AT (1) ATE249461T1 (sr)
AU (1) AU738462B2 (sr)
BG (1) BG64597B1 (sr)
BR (1) BR9813048B1 (sr)
CA (1) CA2306958C (sr)
CO (1) CO4980899A1 (sr)
CZ (1) CZ294482B6 (sr)
DE (1) DE69818084T2 (sr)
DK (1) DK1023292T3 (sr)
EA (1) EA003183B1 (sr)
EE (1) EE04059B1 (sr)
EG (1) EG21730A (sr)
ES (1) ES2205553T3 (sr)
GB (1) GB9721780D0 (sr)
GE (1) GEP20022679B (sr)
HK (1) HK1027807A1 (sr)
HR (1) HRP20000216B1 (sr)
HU (1) HUP0003984A3 (sr)
ID (1) ID24927A (sr)
IL (1) IL135323A (sr)
IN (1) IN184590B (sr)
IS (1) IS2195B (sr)
MA (1) MA24676A1 (sr)
MY (1) MY127470A (sr)
NO (1) NO325030B1 (sr)
NZ (1) NZ503679A (sr)
OA (1) OA11370A (sr)
PE (1) PE121899A1 (sr)
PL (1) PL188477B1 (sr)
PT (1) PT1023292E (sr)
RS (1) RS49710B (sr)
SK (1) SK285331B6 (sr)
TR (1) TR200000976T2 (sr)
TW (1) TW436488B (sr)
UA (1) UA54550C2 (sr)
WO (1) WO1999019327A1 (sr)
ZA (1) ZA989338B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK284596B6 (sk) * 1997-11-27 2005-07-01 Lonza Ag Spôsob výroby (1S,4R)- alebo (1R,4S)-4-(2-amino-6-chlór-9-H- purin-9-yl)-2-cyklopentén-1-metanolu alebo jeho solí
FR2849030A1 (fr) * 2002-12-20 2004-06-25 Isochem Sa Procede de preparation des n-(2-amino-4, 6-dihalogenopyrimidin-5-yl) formamides
GB0320738D0 (en) 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
CN100465174C (zh) * 2006-06-13 2009-03-04 中国科学院上海有机化学研究所 制备光学纯阿巴卡韦的方法
KR101109476B1 (ko) * 2009-06-26 2012-01-31 현대제철 주식회사 실린더 교체용 지그장치
HUE026849T2 (en) 2010-01-27 2016-08-29 Viiv Healthcare Company Corp Service Company Therapeutic combination containing dolutegravir, abacavir and lamivudine
CN104672239A (zh) * 2013-11-26 2015-06-03 上海迪赛诺化学制药有限公司 一种采用一锅法制备阿巴卡韦式v中间体的工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
JPS6175A (ja) * 1984-03-06 1986-01-06 ブリストル−マイア−ズ コムパニ− 神経弛緩剤、1‐フルオロフェニルブチル‐4‐(5‐ハロ‐2‐ピリミジニル)ピペラジン誘導体
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
BE1003815A4 (fr) * 1988-01-20 1992-06-23 Univ Minnesota Nucleosides dideoxydidehydrocarbocyliques et composition pharmaceutique les contenant.
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5329008A (en) * 1993-04-07 1994-07-12 Glaxo Inc. Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone
GB9402161D0 (en) * 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
SK285228B6 (sk) * 1997-05-13 2006-09-07 Lonza Ag Spôsob výroby racemického alebo opticky aktívnehoderivátu 4-(hydroxymetyl)-2-cyklopenténu a racemicky N-butyryl-1-amino-4- (hydroxymetyl)-2-cyklopentén

Also Published As

Publication number Publication date
EP1023292A1 (en) 2000-08-02
CA2306958C (en) 2007-09-04
MA24676A1 (fr) 1999-07-01
CA2306958A1 (en) 1999-04-22
PL339904A1 (en) 2001-01-15
BR9813048B1 (pt) 2010-07-13
ZA989338B (en) 2000-04-13
GEP20022679B (en) 2002-04-25
CZ294482B6 (cs) 2005-01-12
UA54550C2 (uk) 2003-03-17
ES2205553T3 (es) 2004-05-01
CO4980899A1 (es) 2000-11-27
BG104352A (en) 2001-02-28
MY127470A (en) 2006-12-29
JP2001519432A (ja) 2001-10-23
HUP0003984A2 (hu) 2001-04-28
AU738462B2 (en) 2001-09-20
HRP20000216A2 (en) 2000-08-31
HUP0003984A3 (en) 2002-12-28
IS2195B (is) 2007-01-15
US6646125B1 (en) 2003-11-11
AR014921A1 (es) 2001-04-11
PE121899A1 (es) 1999-12-20
IS5423A (is) 2000-03-28
JP4531250B2 (ja) 2010-08-25
NO20001896D0 (no) 2000-04-12
KR100543845B1 (ko) 2006-01-23
DE69818084T2 (de) 2004-07-15
EA200000318A1 (ru) 2000-12-25
EG21730A (en) 2002-02-27
WO1999019327A1 (en) 1999-04-22
EP1023292B1 (en) 2003-09-10
GB9721780D0 (en) 1997-12-10
SK5362000A3 (en) 2001-03-12
DK1023292T3 (da) 2003-11-10
AU9547698A (en) 1999-05-03
SK285331B6 (sk) 2006-11-03
KR20010015744A (ko) 2001-02-26
EE04059B1 (et) 2003-06-16
ATE249461T1 (de) 2003-09-15
YU20200A (sh) 2003-02-28
AP1182A (en) 2003-06-18
TW436488B (en) 2001-05-28
IN184590B (sr) 2000-09-09
NO20001896L (no) 2000-06-13
BR9813048A (pt) 2000-08-15
IL135323A (en) 2004-07-25
CZ20001367A3 (cs) 2000-10-11
AP2000001790A0 (en) 2000-06-30
PT1023292E (pt) 2004-02-27
EE200000162A (et) 2001-04-16
ID24927A (id) 2000-08-31
EA003183B1 (ru) 2003-02-27
CN1160354C (zh) 2004-08-04
OA11370A (en) 2004-01-27
HK1027807A1 (en) 2001-01-23
HRP20000216B1 (en) 2002-08-31
BG64597B1 (bg) 2005-08-31
TR200000976T2 (tr) 2000-11-21
NO325030B1 (no) 2008-01-21
DE69818084D1 (de) 2003-10-16
NZ503679A (en) 2002-09-27
PL188477B1 (pl) 2005-02-28
CN1281457A (zh) 2001-01-24
IL135323A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
YU48020B (sh) Postupak za dobijanje novih farmakoloških aktivnih ketholnih derivata
RS49531B (sr) Estrogen agonisti/antagonisti
IT1286067B1 (it) Esteri di acidi ossimsolfonici e loro impiego come acidi solfonici latenti
RS49710B (sr) Postupak sinteze hloropurinskih intermedijara
ATE46501T1 (de) Abkoemmlinge der guanidinomethylbenzoesaeure.
YU48238B (sh) Derivti imidazopiridina, postupak za dobijanje smeša sa njima i postupak za dobijanje derivata imidazopiridina
YU46547B (sh) 1,4-dihidropiridini i postupak za njihovo dobijanje
IS2477B (is) Aðferð til að framleiða díoxanediksýruestera
JPS57158769A (en) Preparation of 2-substituted hydroxyimino-2-(5-amino-1,2,4- thiadiazol-3-yl)acetic acid or its salt, and their intermediate
YU65899A (sh) Stabilizovani karbapenem intermedijari i sintetska upotreba
KR910014380A (ko) 이미자조피리다진 화합물, 그의 제법 및 용도
JPS57118555A (en) Leucotriene-analog compound, its preparation, and leucotriene-biosynthesis inhibiting agent containing said compound as active component
NO982107L (no) Fremstilling av et salt av klavulansyre
EP1227081A4 (en) PROCESS FOR THE PREPARATION OF OXYMINOALKANOIC ACID DERIVATIVES
JPS5772981A (en) 1,8-naphthyridine derivative and its salt
JPS57123140A (en) Ml-236b carboxylic acid amine salt and remedy for hyperlipemia containing said salt as active component
YU48445B (sh) Postupak za dobijanje novih 4-hidroksikumarin i 1 3-indandion derivata
JPS54112856A (en) Preparation of thiophene derivative
ATE67194T1 (de) Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
IE44888L (en) 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and¹processes for the preparation thereof
JPS57181032A (en) Novel cyclohexene derivative
JPS57116048A (en) Novel quinoline derivative
JPS57197279A (en) Novel hexaminum compound and its preparation
JPS5653685A (en) Production of cephalosporin derivative
KR890006565A (ko) 2-아미노-3,5-디브로모벤질아민 유도체의 제조방법